Benign prostatic hyperplasia: a global challenge of the ageing population

Affiliations

¹ Genitourinary Oncology, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT 84112, USA. Electronic address: Nicolas.Sayegh@hci.utah.edu.
² Division of Urology, Department of Surgery, University of Utah, Salt Lake City, UT 84112, USA.

Free article

Comment

Nicolas Sayegh et al. Lancet Healthy Longev. 2022 Nov.

Free article

. 2022 Nov;3(11):e725-e726.

doi: 10.1016/S2666-7568(22)00243-4. Epub 2022 Oct 20.

¹ Genitourinary Oncology, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT 84112, USA. Electronic address: Nicolas.Sayegh@hci.utah.edu.
² Division of Urology, Department of Surgery, University of Utah, Salt Lake City, UT 84112, USA.

No abstract available

Conflict of interest statement

We declare no competing interests.

The global, regional, and national burden of benign prostatic hyperplasia in 204 countries and territories from 2000 to 2019: a systematic analysis for the Global Burden of Disease Study 2019.
GBD 2019 Benign Prostatic Hyperplasia Collaborators. GBD 2019 Benign Prostatic Hyperplasia Collaborators. Lancet Healthy Longev. 2022 Nov;3(11):e754-e776. doi: 10.1016/S2666-7568(22)00213-6. Epub 2022 Oct 20. Lancet Healthy Longev. 2022. PMID: 36273485 Free PMC article.